Cargando…
Forecasting the cytokine storm following systemic interleukin (IL)-2 administration
Extensive clinical experience has shown that systemic interleukin (IL)-2 administration can induce complete or partial regression of renal cell cancer (RCC) metastases in 15 to 20 % of patients. Since IL-2 has no direct anti-cancer effects, it is believed that cancer regression is mediated either by...
Autores principales: | Panelli, Monica C, White, Richard, Foster, Mareva, Martin, Brian, Wang, Ena, Smith, Kina, Marincola, Francesco M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC434535/ https://www.ncbi.nlm.nih.gov/pubmed/15175100 http://dx.doi.org/10.1186/1479-5876-2-17 |
Ejemplares similares
-
Polarized monocyte response to cytokine stimulation
por: Nagorsen, Dirk, et al.
Publicado: (2005) -
Gene-expression profiling of the response of peripheral blood mononuclear cells and melanoma metastases to systemic IL-2 administration
por: Panelli, Monica C, et al.
Publicado: (2002) -
Delayed polarization of mononuclear phagocyte transcriptional program by type I interferon isoforms
por: Stroncek, David F, et al.
Publicado: (2005) -
Molecular signatures induced by interleukin-2 on peripheral blood mononuclear cells and T cell subsets
por: Jin, Ping, et al.
Publicado: (2006) -
Gene expression profiling of cutaneous wound healing
por: Deonarine, Kavita, et al.
Publicado: (2007)